TipRanks
Enanta Pharmaceuticals (DE:9EP)
FRANKFURT:9EP
Germany Market
9EP
Enanta Pharmaceuticals
RESEARCH TOOLSreports

Enanta Pharmaceuticals (9EP) Balance Sheet

0 Followers

Enanta Pharmaceuticals Balance Sheet

Enanta Pharmaceuticals's total assets for Q3 2026 were $296.87M, a decrease of -5.67% from the previous quarter. DE:9EP total liabilities were $195.80M for the fiscal quarter, a -1.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Sep 25Sep 24Sep 23Sep 22Sep 21
Total Assets
$ 280.73M$ 376.65M$ 462.27M$ 380.59M$ 440.86M
Total Liabilities
$ 216.01M$ 247.84M$ 245.54M$ 59.26M$ 41.43M
Total Equity Gross Minority
$ 64.72M$ 128.81M$ 216.74M$ 321.33M$ 399.43M
Other Metrics
Currency in USD

Enanta Pharmaceuticals Debt to Assets